Clinical Trial Update: Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment [Phase 1, Phase 2]

View source ↗

Summary

This is a completed Phase 1/2 clinical trial evaluating the safety and efficacy of the lenalidomide and dexamethasone combination in relapsed or treatment-resis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Chronic Lymphatic Leukemia | Phase 1, Phase 2 | Status: COMPLETED